AP NEWS

Global Candidiasis Drugs Market Outlook Report, 2019-2023 - Advances in Diagnosis of Antifungal Resistant Pathogens to Drive Market Growth - ResearchAndMarkets.com

February 6, 2019

DUBLIN--(BUSINESS WIRE)--Feb 6, 2019--The “Global Candidiasis Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The candidiasis drugs market will register a CAGR of almost 4% by 2023.

Advances in diagnosis of antifungal resistant pathogens to drive market growth

Although the currently available antifungal drugs are killing various species of candidiasis, some fungi can develop the ability to defend these drugs. For instance, Candida auris, an emerging antifungal-resistant yeast, is frequently resistant to multiple antifungal drugs that were used to treat Candida infections.

Moreover, it can cause serious bloodstream infections in hospitalized patients. Hence, advanced technologies are required for the diagnosis of such fungal diseases caused by antifungal-resistant pathogens.

Rising awareness about candidiasis

The signs and symptoms of candidiasis are very broad, and they also depend on the type of candidiasis infection. They sometimes resemble the symptoms of other diseases caused by bacteria. Hence, confirmatory diagnosis methods are required to confirm the disease after assessing the initial symptoms.

Early detection can aid in treating them more effectively. Therefore, to create awareness about the disease and treatment options and avoid delay in diagnosis, the CDC is providing information about candidiasis, and its causes, risk factors, transmission, diagnosis, and treatment in the US.

Side effects of available drugs

Although several off-label medications are available for the symptomatic treatment of candidiasis, the side effects associated with them are decreasing their preference. For instance, polyene antifungal medicine, nystatin causes mouth irritation, diarrhea, nausea, vomiting, stomach upset, rashes, hives, and skin irritation.

Although azole medications such as fluconazole, voriconazole, and miconazole are usually well tolerated, they cause side effects such as a headache, nausea, abdominal pain, diarrhea, vomiting, dyspepsia, liver damages, and rashes.

Competitive Landscape

The market appears to be fragmented, and with the presence of several companies including Merck and Pfizer, the competitive environment is quite intense.

Key Players

Astellas Pharma Bayer Fresenius Merck Pfizer

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 04: MARKET SIZING

Market definition Market sizing 2018 Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

PART 06: MARKET SEGMENTATION BY TYPE

Comparison by type Azoles - Market size and forecast 2018-2023 Echinocandins - Market size and forecast 2018-2023 Other drugs - Market size and forecast 2018-2023 Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic comparison North America - Market size and forecast 2018-2023 Europe - Market size and forecast 2018-2023 Asia - Market size and forecast 2018-2023 ROW - Market size and forecast 2018-2023 Key leading countries Market opportunity

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

Overview Landscape disruption Competitive scenario

PART 12: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors Astellas Pharma Bayer Fresenius Merck Pfizer

For more information about this report visit https://www.researchandmarkets.com/research/btts6l/global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20190206005534/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Diseases Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 02/06/2019 11:47 AM/DISC: 02/06/2019 11:47 AM

http://www.businesswire.com/news/home/20190206005534/en

AP RADIO
Update hourly